These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 19012393

  • 1. Assessment of additive/nonadditive effects in structure-activity relationships: implications for iterative drug design.
    Patel Y, Gillet VJ, Howe T, Pastor J, Oyarzabal J, Willett P.
    J Med Chem; 2008 Dec 11; 51(23):7552-62. PubMed ID: 19012393
    [Abstract] [Full Text] [Related]

  • 2. Synthetic library design.
    Huwe CM.
    Drug Discov Today; 2006 Aug 11; 11(15-16):763-7. PubMed ID: 16846805
    [Abstract] [Full Text] [Related]

  • 3. A critical appraisal of structure-based drug design.
    Tintelnot-Blomley M, Lewis RA.
    IDrugs; 2006 Feb 11; 9(2):114-8. PubMed ID: 16523401
    [Abstract] [Full Text] [Related]

  • 4. Pyrazole CCK(1) receptor antagonists. Part 1: Solution-phase library synthesis and determination of Free-Wilson additivity.
    McClure K, Hack M, Huang L, Sehon C, Morton M, Li L, Barrett TD, Shankley N, Breitenbucher JG.
    Bioorg Med Chem Lett; 2006 Jan 01; 16(1):72-6. PubMed ID: 16236513
    [Abstract] [Full Text] [Related]

  • 5. Descriptor-free molecular discovery in large libraries by adaptive substituent reordering.
    McAllister SR, Feng XJ, DiMaggio PA, Floudas CA, Rabinowitz JD, Rabitz H.
    Bioorg Med Chem Lett; 2008 Nov 15; 18(22):5967-70. PubMed ID: 18851908
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Selective optimization of side activities: another way for drug discovery.
    Wermuth CG.
    J Med Chem; 2004 Mar 11; 47(6):1303-14. PubMed ID: 14998318
    [No Abstract] [Full Text] [Related]

  • 12. Natural product hybrids as new leads for drug discovery.
    Tietze LF, Bell HP, Chandrasekhar S.
    Angew Chem Int Ed Engl; 2003 Sep 05; 42(34):3996-4028. PubMed ID: 12973759
    [Abstract] [Full Text] [Related]

  • 13. Expediting drug discovery: recent advances in fast medicinal chemistry--optimization of hits and leads.
    Edwards PJ, Allart B, Andrews MJ, Clase JA, Menet C.
    Curr Opin Drug Discov Devel; 2006 Jul 05; 9(4):425-44. PubMed ID: 16889227
    [Abstract] [Full Text] [Related]

  • 14. Current directions in the evolution of compound libraries.
    Webb TR.
    Curr Opin Drug Discov Devel; 2005 May 05; 8(3):303-8. PubMed ID: 15892244
    [Abstract] [Full Text] [Related]

  • 15. Receptor-assisted combinatorial chemistry: thermodynamics and kinetics in drug discovery.
    Cheeseman JD, Corbett AD, Gleason JL, Kazlauskas RJ.
    Chemistry; 2005 Mar 04; 11(6):1708-16. PubMed ID: 15565741
    [Abstract] [Full Text] [Related]

  • 16. Design of diversity and focused combinatorial libraries in drug discovery.
    Young SS, Ge N.
    Curr Opin Drug Discov Devel; 2004 May 04; 7(3):318-24. PubMed ID: 15216935
    [Abstract] [Full Text] [Related]

  • 17. Recent trends in library design: 'rational design' revisited.
    Schnur DM.
    Curr Opin Drug Discov Devel; 2008 May 04; 11(3):375-80. PubMed ID: 18428091
    [Abstract] [Full Text] [Related]

  • 18. Metal complexes in medicinal chemistry: new vistas and challenges in drug design.
    Thompson KH, Orvig C.
    Dalton Trans; 2006 Feb 14; (6):761-4. PubMed ID: 16437168
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The hidden component of size in two-dimensional fragment descriptors: side effects on sampling in bioactive libraries.
    Dixon SL, Koehler RT.
    J Med Chem; 1999 Jul 29; 42(15):2887-900. PubMed ID: 10425098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.